News tagged ‘BasicResearch’ clear
- Using a novel three-part screening process, scientists at Dana-Farber
Cancer Institute have identified a gene that is made inappropriately in
about a third of all breast cancers. The discovery, reached in
collaboration with researchers at Brigham and Womens Hospital (BWH) and
the Broad Institute of Harvard and MIT, is reported in the June 15,
2007, issue of the journal Cell.
Tags: BasicResearch, BreastCancer
- The license grants the companies exclusive rights to develop human
monoclonal antibodies to treat and protect against group 1 influenza
viruses, which include the H1N1 virus.
- The grant will help research into a vaccine that targets parts of the
flu virus that do not change from one strain to the next, removing the
need to create updated vaccines for seasonal flus or pandemics.
Tags: BasicResearch, Influenza
- Dana-Farber Cancer Institute and Eli Lilly and Company announced a multiyear collaboration to research new medicines under development to fight cancer.
Tags: BasicResearch, Partnerships
- Edward J. Benz, Jr., MD, offers his thoughts on the introduction of the
21st Century Cancer Access to Life-Saving Early detection, Research and
Treatment (ALERT) Act.
Tags: BasicResearch, Prevention
- Dana-Farber Cancer Institute researchers have isolated a new type of energy-burning fat cell called "beige fat" in adult humans which they say may have therapeutic potential for treating obesity.
- Dana-Farber Cancer Institute is expanding its research footprint by moving into five floors at Longwood Center (360 Longwood Avenue), beginning later this month.
Tags: BasicResearch, TranslationalResearch
- Dana-Farber Cancer Institute and Harvard T.H. Chan School of Public Health in Boston and the Irish Cancer Society have formed the Boston-Ireland Prostate Cancer Collaboration. This new entity will conduct and facilitate exchanges of researchers and knowledge between Boston and Ireland.
Tags: BasicResearch, ProstateCancer
- David Steensma, MD, leads Dana-Farber's efforts as part of a six-institution, $16 million research consortium advancing the treatments and outcomes for patients suffering from Myelodysplastic Syndromes (MDS), a group of diseases that affect the bone marrow and blood.
- David Pellman, MD, a pediatric oncologist at Dana-Farber and
Children's Hospital Boston, is one of 56 scientists just selected as an
investigator of the Howard Hughes Medical Institute, a non-profit
medical research organization that ranks as one of the nation's largest
Tags: BasicResearch, ChildhoodCancer
Showing 21-30 of 142 items